301408 华人健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.7237.93318.5659.29914.215
总资产报酬率 ROA (%)1.5653.1917.0714.2817.559
投入资产回报率 ROIC (%)1.7733.5978.2565.0619.192

边际利润分析
销售毛利率 (%)31.86230.63932.57534.86736.260
营业利润率 (%)4.7404.0226.5203.9576.167
息税前利润/营业总收入 (%)5.1764.5007.2785.0626.746
净利润/营业总收入 (%)3.6823.0994.9122.9824.602

收益指标分析
经营活动净收益/利润总额(%)92.88992.52597.84295.06898.103
价值变动净收益/利润总额(%)0.6220.5310.3780.8820.479
营业外收支净额/利润总额(%)-0.651-0.8020.9401.7733.181

偿债能力分析
流动比率 (X)1.2561.4391.2491.2611.620
速动比率 (X)0.8211.0460.8480.7671.089
资产负债率 (%)57.02157.14163.24060.17144.406
带息债务/全部投入资本 (%)42.96745.34045.59735.87332.440
股东权益/带息债务 (%)113.524102.59394.517128.924208.146
股东权益/负债合计 (%)73.57873.75458.14566.172125.152
利息保障倍数 (X)11.0798.83010.4594.89917.935

营运能力分析
应收账款周转天数 (天)40.91045.50841.71238.94835.124
存货周转天数 (天)101.60690.01680.29287.34477.852